Fifteen start-ups have been awarded Proof-of-Concept (POC) and Proof-of-Value (POV) grants totalling $6 million under SPRING Singapore’s Technology Enterprise Commercialisation Scheme (TECS), which aims to bring potentially disruptive technologies closer to the market.
The 15 projects cover a wide spectrum of technology areas including medical devices, electronics, engineering, water and environment, as well as infocomm.
Among the projects supported are three which could make a notable impact on the healthcare sector when commercialised. One of them, Neurostyle, is developing a new way to teach the brain to ‘rewire’ itself - through virtual reality games - that can help stroke patients recover the movement in their affected limbs. Another start-up, Hexalotus Technology, is coming up with a 3D model that will improve the planning and treatment of liver cancer. Its web-based platform has the added advantage of facilitating consultation and assistance among doctors. T.Ware is developing a therapy system to calm autism patients who can go into uncontrollable fits. Using its T.Jacket which simulates deep pressure massage, a therapist can customise the rhythm and pressure of the ‘hug’ of the jacket according to the patient’s needs. A single therapist can thus attend to many patients at the same time.
Click here to read the full story.
Thanks for reading to the end of this story!
We would be grateful if you would consider joining as a member of The EB Circle. This helps to keep our stories and resources free for all, and it also supports independent journalism dedicated to sustainable development. For a small donation of S$60 a year, your help would make such a big difference.